T. Rowe Price
TROW
104.07
+0.47
+0.45%
T. Rowe Price
US · TROW
#862 by market cap
Listed 1970
104.07
+0.47
+0.45%
Live - 5344 symbols - heartbeat 469s ago
· 2026-10-08 06:30
Pre-market
103.50
-0.55%
After-hours
104.07
0.00%
- Market cap
- 22.20B
- P/E (TTM)i
- 10.45
- P/Bi
- 2.02
- EPSi
- 9.24
- Div yieldi
- 4.94%
- 52W posi
- 56%
Reader sentiment
Are you bullish or bearish on TROW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.29, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.12% YoY
Margins
- Gross margin
- 51.27%
- Operating margin
- 33.87%
- Net margin
- 27.84%
Key ratios & quality
- PEG ratioi
- 1.02
- Altman Z-Scorei
- 8.29
PEG uses trailing P/E against the 3-year net income growth rate (10.24%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.37B | 5.62B | 6.21B | 7.67B | 6.49B | 6.46B | 7.09B | 7.31B |
| Gross profit | 3.13B | 3.23B | 3.59B | 4.68B | 3.57B | 3.21B | 3.68B | 3.75B |
| Selling & admin expenses | 395.60M | 418.70M | 399.80M | 968.70M | 1.07B | 1.17B | 1.21B | 1.27B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.35B | 2.39B | 2.75B | 3.71B | 2.50B | 2.04B | 2.48B | 2.48B |
| Pretax profit | 2.38B | 2.93B | 3.24B | 3.99B | 1.95B | 2.49B | 2.82B | 2.88B |
| Tax | 615.90M | 678.40M | 718.90M | 896.10M | 498.60M | 654.60M | 683.80M | 667.20M |
| Net profit | 1.77B | 2.25B | 2.52B | 3.10B | 1.45B | 1.84B | 2.14B | 2.21B |
| Basic EPS | 7 | 9 | 10 | 13 | 7 | 8 | 9 | 9 |
| Diluted EPS | 7.27 | 8.70 | 9.98 | 13.12 | 6.70 | 7.76 | 9.15 | 9.24 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.76B | 1.72B | 1.89B | 1.93B | 1.86B | 1.91B |
| Gross profit | 922.00M | 828.30M | 1.00B | 995.30M | 1.02B | 894.80M |
| Selling & admin expenses | 297.00M | 123.80M | 306.20M | 350.90M | 315.20M | 125.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 625.00M | 509.50M | 698.50M | 644.40M | 708.50M | 563.70M |
| Pretax profit | 667.00M | 713.80M | 881.60M | 613.10M | 632.20M | 909.60M |
| Tax | 161.90M | 157.70M | 195.10M | 152.50M | 148.10M | 214.20M |
| Net profit | 505.10M | 556.10M | 686.50M | 460.60M | 484.10M | 695.40M |
| Basic EPS | 2 | 2 | 3 | 2 | 2 | 3 |
| Diluted EPS | 2.15 | 2.24 | 2.87 | 1.99 | 2.23 | 2.88 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.97B | 2.43B | 3.01B | 2.58B | 2.50B | 2.87B | 3.53B | 4.31B |
| Cash & ST investments | 1.43B | 1.78B | 2.15B | 1.52B | 1.76B | 2.07B | 2.65B | 3.38B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 7.69B | 9.33B | 10.66B | 12.51B | 11.64B | 12.28B | 13.47B | 14.34B |
| Total current liabilities | 282.70M | 246.30M | 272.70M | 508.90M | 452.70M | 489.10M | 440.60M | 407.60M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 824,700,000.00 | 1,107,300,000.00 | 1,390,300,000.00 | 2,255,300,000.00 | 1,956,400,000.00 | 1,987,600,000.00 | 2,021,900,000.00 | 2,288,600,000.00 |
| Total equity | 6.86B | 8.22B | 9.27B | 10.25B | 9.69B | 10.29B | 11.45B | 12.05B |
| Retained earnings | 5.46B | 6.44B | 7.03B | 8.08B | 8.41B | 9.08B | 10.04B | 10.87B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.77B | 3.92B | 4.53B | 4.31B | 4.64B | 4.18B |
| Cash & ST investments | 2.84B | 3.06B | 3.63B | 3.38B | 3.73B | 3.23B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 13.99B | 14.34B | 14.73B | 14.34B | 14.39B | 15.36B |
| Total current liabilities | 642.20M | 357.90M | 396.20M | 407.60M | 501.90M | 433.60M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 2,461,400,000.00 | 2,529,300,000.00 | 2,761,000,000.00 | 2,288,600,000.00 | 2,517,600,000.00 | 3,184,400,000.00 |
| Total equity | 11.53B | 11.81B | 11.97B | 12.05B | 11.88B | 12.17B |
| Retained earnings | 10.24B | 10.46B | 10.82B | 10.87B | 10.79B | 11.02B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.62B | 1.52B | 1.92B | 3.45B | 2.36B | 1.22B | 1.69B | 1.75B |
| Depreciation & amortization | 159.50M | 190.80M | 189.60M | 204.80M | 645.80M | 481.60M | 504.20M | 605.50M |
| Free cash flow | 1.45B | 1.32B | 1.70B | 3.21B | 2.12B | 911.20M | 1.26B | 1.48B |
| Dividends paid | -694.30M | -733.90M | -845.80M | -1.70B | -1.11B | -1.12B | -1.14B | -1.14B |
| Stock buybacks / issuance | -1.09B | -705.80M | -1.20B | -1.14B | -849.80M | -254.40M | -337.20M | -620.90M |
| Ending cash balance | 1.50B | 1.86B | 2.26B | 1.62B | 1.87B | 2.14B | 2.71B | 3.42B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 632.90M | 529.90M | 609.30M | -18.70M | 824.30M | 517.30M |
| Depreciation & amortization | 63.60M | 185.70M | -45.60M | 401.80M | 68.80M | 136.90M |
| Free cash flow | 550.90M | 467.70M | 546.00M | -85.40M | 762.30M | 450.90M |
| Dividends paid | -289.50M | -285.60M | -283.40M | -284.50M | -289.10M | -282.10M |
| Stock buybacks / issuance | -215.20M | -113.10M | -153.50M | -139.10M | -333.50M | -167.30M |
| Ending cash balance | 2.89B | 3.13B | 3.68B | 3.42B | 3.80B | 3.31B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 30.76 | 31.39 | 31.16 | 35.89 | 17.04 | 19.02 | 20.60 | 19.21 |
| ROA %i | 24.14 | 24.40 | 23.09 | 25.92 | 12.60 | 14.58 | 15.88 | 14.64 |
| ROIC %i | 30.76 | 30.71 | 30.54 | 35.05 | 16.50 | 18.38 | 20.01 | 18.57 |
| 5-year avg ROE %i | 26.02 | 27.48 | 28.90 | 31.10 | 29.10 | 26.90 | 24.74 | 22.35 |
| EBIT margin %i | 43.67 | 42.49 | 44.24 | 48.36 | 38.47 | 31.55 | 34.91 | 33.87 |
| FCF / sales %i | 27.01 | 23.46 | 27.46 | 41.88 | 32.70 | 14.10 | 17.79 | 20.22 |
| Current ratioi | 6.99 | 9.86 | 11.06 | 5.07 | 5.53 | 5.88 | 8.01 | 10.57 |
| Quick ratioi | 6.99 | 9.86 | 11.06 | 5.07 | 5.53 | 5.88 | 8.01 | 10.57 |
| Debt / assetsi | 0.00 | 1.57 | 1.45 | 1.99 | 2.83 | 2.51 | 2.07 | 3.12 |
| LT debt / equityi | -- | 2.06 | 2.00 | 2.76 | 3.73 | 3.25 | 2.69 | 4.12 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 8.55 | 9.45 | 8.53 | 12.61 | 4.92 | 1.34 | -2.58 | 4.08 |
| Net income CAGR (3Y) %i | 14.53 | 20.60 | 16.57 | 18.83 | -9.92 | -8.99 | -12.01 | 10.24 |
| FCF CAGR (3Y) %i | 1.72 | 290.12 | 239.90 | 30.33 | 17.20 | -18.84 | -26.76 | -11.33 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.47 | 19.39 | 19.28 | 19.21 | 19.31 | 20.10 |
| ROA %i | 14.63 | 14.48 | 14.28 | 14.64 | 14.40 | 14.59 |
| ROIC %i | 18.75 | 18.69 | 18.62 | 18.57 | 18.51 | 19.29 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 34.97 | 33.62 | 33.76 | 33.87 | 34.57 | 34.45 |
| FCF / sales %i | 17.99 | 16.51 | 16.23 | 20.22 | 22.82 | 22.05 |
| Current ratioi | 5.87 | 10.95 | 11.44 | 10.57 | 9.24 | 9.63 |
| Quick ratioi | 5.87 | 10.95 | 11.44 | 10.57 | 9.24 | 9.63 |
| Debt / assetsi | 3.37 | 3.31 | 3.09 | 3.12 | 3.04 | 2.80 |
| LT debt / equityi | 4.54 | 4.50 | 4.21 | 4.12 | 4.06 | 3.90 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Investment advisory fees is the largest reported line at 91.48% of revenue, across 4 reported segments.
- The next-largest line, Administrative, distribution, services, and other fees, is a distant second at 7.56% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Investment advisory fees91.48%
Administrative, distribution, services, and other fees7.56%
Capital allocation-based income (loss)0.62%
Performance-based advisory fees0.34%
Quote time 2026-10-08 06:30:23 · For reference only, not investment advice and not tailored to your situation.